Emergency resection is an independent risk factor for decreased long-term overall survival in colorectal cancer: a matched-pair analysis | World Journal of Surgical Oncology | Full Text
27 Survival analysis | The Epidemiologist R Handbook
223Ra-Dichloride in castration-resistant metastatic prostate cancer: improving outcomes and identifying predictors of survival in clinical practice | European Journal of Nuclear Medicine and Molecular Imaging
Survival (time to event) data: median survival times | The BMJ
The impact of the time to start radiation therapy on overall survival in newly diagnosed glioblastoma | Journal of Neuro-Oncology
Differences in survival times between clusters Survival times with... | Download Scientific Diagram
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
Entropy | Free Full-Text | Focused Information Criterion for Restricted Mean Survival Times: Non-Parametric or Parametric Estimators
High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib | Leukemia
Survival Analysis in R
Real-World Progression-Free Survival as an Endpoint in Advanced Non-Small-Cell Lung Cancer: Replicating Atezolizumab and Docetaxel Arms of the OAK Trial Using Data Derived From Electronic Health Records | medRxiv
27 Survival analysis | The Epidemiologist R Handbook
Full article: Impact of delays in definitive treatment on overall survival: a National Cancer Database study of patients with Hodgkin lymphoma
Survival Analysis in R
Real-world treatment and survival of patients with advanced non-small cell lung Cancer: a German retrospective data analysis | BMC Cancer | Full Text
The prolonged interval between induction chemotherapy and radiotherapy is associated with poor prognosis in patients with nasopharyngeal carcinoma | Radiation Oncology | Full Text
Cancers | Free Full-Text | Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study
Overall survival in advanced epidermal growth factor receptor mutated non-small cell lung cancer using different tyrosine kinase inhibitors in The Netherlands: a retrospective, nationwide registry study - The Lancet Regional Health –
Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC | NEJM
Overall survival from date of LMD relapse. Median survival 39 days (95%... | Download Scientific Diagram
Overall survival from the date of progression.
Progression-free survival, disease-free survival and other composite end points in oncology: improved reporting is needed | Nature Reviews Clinical Oncology
Assessing CAR T-Cell Therapy Response Using Genome-Wide Sequencing of Cell-Free DNA in Patients With B-Cell Lymphomas - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
A Cumulative of overall survival over 28 days between severe patients... | Download Scientific Diagram
Overall survival in days from initial diagnosis | Download Scientific Diagram
